ISSN 1673-3770 CN 37-1437/R
Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2025, Vol. 39 ›› Issue (1): 141-145.doi: 10.6040/j.issn.1673-3770.0.2023.278
• Review • Previous Articles Next Articles
WANG Manxian, ZHENG Quan, YANG Liang
CLC Number:
| [1] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国变应性鼻炎诊断和治疗指南(2022年,修订版)[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(2): 106-129. doi:10.3760/cma.j.cn115330-20211228-00828 [2] 倪璟滋, 万文锦. 变应性鼻炎健康相关生活质量研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3)110-115, 122. doi: 10.6040/j.issn.1673-3770.1.2021.165 NI Jingzi, WAN Wenjin. Research progress on health-related quality of life in allergic rhinitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3)110-115, 122. doi: 10.6040/j.issn.1673-3770.1.2021.165 [3] Biering LMK, Tea S, Allan L. Allergic rhinitis and allergic sensitisation are still increasing among Danish adults[J]. Allergy, 2020, 75(3): 660-668. doi:10.1111/all.14046. [4] Tong H, Gao L, Deng YQ, et al. Prevalence of allergic rhinitis and associated risk factors in 6 to 12 years schoolchildren from Wuhan in central China: a cross-sectional study[J]. Am J Rhinol Allergy, 2020, 34(5): 632-641. doi:10.1177/1945892420920499 [5] Li F, Zhou YC, Li SH, et al. Prevalence and risk factors of childhood allergic diseases in eight metropolitan cities in China: a multicenter study[J]. BMC Public Health, 2011, 11: 437. doi:10.1186/1471-2458-11-437 [6] Ma TT, Wang XD, Zhuang Y, et al. Prevalence and risk factors for allergic rhinitis in adults and children living in different grassland regions of Inner Mongolia[J]. Allergy, 2020, 75(1): 234-239. doi:10.1111/all.13941 [7] Sasaki M, Morikawa E, Yoshida K, et al. The change in the prevalence of wheeze, eczema and rhino-conjunctivitis among Japanese children: findings from 3 nationwide cross-sectional surveys between 2005 and 2015[J]. Allergy, 2019, 74(8): 1572-1575. doi:10.1111/all.13773 [8] Avdeeva KS, Reitsma S, Fokkens WJ. Direct and indirect costs of allergic and non-allergic rhinitis in the Netherlands[J]. Allergy, 2020, 75(11): 2993-2996. doi:10.1111/all.14457 [9] Esposito S, Soto-Martinez ME, Feleszko W, et al. Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidence[J]. Curr Opin Allergy Clin Immunol, 2018, 18(3): 198-209. doi:10.1097/ACI.0000000000000433 [10] Meng Q, Li P, Li Y, et al. Broncho-vaxom alleviates persistent allergic rhinitis in patients by improving Th1/Th2 cytokine balance of nasal mucosa[J]. Rhinology, 2019, 57(6): 451-459. doi:10.4193/Rhin19.161 [11] Okubo K, Kurono Y, Ichimura K, et al. Japanese guidelines for allergic rhinitis 2020[J]. Allergol Int, 2020, 69(3): 331-345. doi:10.1016/j.alit.2020.04.001 [12] Muñoz-Bellido FJ, Moreno E, Dávila I. Dupilumab: a review of present indications and off-label uses[J]. J Investig Allergol Clin, 2022, 32(2): 97-115. doi:10.18176/jiaci.0682 [13] Gonzalez-Figueroa P, Roco JA, Papa I, et al. Follicular regulatory T cells produce neuritin to regulate B cells[J]. Cell, 2021, 184(7): 1775-1789.e19. doi:10.1016/j.cell.2021.02.027 [14] Golebski K, Layhadi JA, Sahiner U, et al. Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response[J]. Immunity, 2021, 54(2): 291-307.e7. doi:10.1016/j.immuni.2020.12.013 [15] Edwards MR, Walton RP, Jackson DJ, et al. The potential of anti-infectives and immunomodulators as therapies for asthma and asthma exacerbations[J]. Allergy, 2018, 73(1): 50-63. doi:10.1111/all.13257 [16] Yin J, Xu BP, Zeng XT, et al. Broncho-Vaxom in pediatric recurrent respiratory tract infections: a systematic review and meta-analysis[J]. Int Immunopharmacol, 2018, 54: 198-209. doi:10.1016/j.intimp.2017.10.032 [17] Ferrara F, Rial A, Suárez N, et al. Polyvalent bacterial lysate protects against pneumonia independently of neutrophils, IL-17A or caspase-1 activation[J]. Front Immunol, 2021, 12: 562244. doi:10.3389/fimmu.2021.562244 [18] Parola C, Salogni L, Vaira X, et al. Selective activation of human dendritic cells by OM-85 through a NF-kB and MAPK dependent pathway[J]. PLoS One, 2013, 8(12): e82867. doi:10.1371/journal.pone.0082867 [19] Luan H, Zhang Q, Wang L, et al. OM85-BV induced the productions of IL-1β, IL-6, and TNF-α via TLR4- and TLR2-mediated ERK1/2/NF-κB pathway in RAW264.7 cells[J]. J Interf Cytokine Res, 2014, 34(7): 526-536. doi:10.1089/jir.2013.0077 [20] Sun Yuting, Zhou Liyu, Chen Weikai, et al. Immune metabolism: a bridge of dendritic cells function[J]. Int Rev Immunol, 2022, 41(3):313-325. doi: 10.1080/08830185.2021.1897124 [21] Suárez N, Ferrara F, Rial A, et al. Bacterial lysates as immunotherapies for respiratory infections: methods of preparation[J]. Front Bioeng Biotechnol, 2020, 8: 545. doi:10.3389/fbioe.2020.00545 [22] Kearney SC, Dziekiewicz M, Feleszko W. Immunoregulatory and immunostimulatory responses of bacterial lysates in respiratory infections and asthma[J]. Ann Allergy Asthma Immunol, 2015, 114(5): 364-369. doi:10.1016/j.anai.2015.02.008 [23] Le Souëf P. Viral infections in wheezing disorders[J]. Eur Respir Rev, 2018, 27(147): 170133. doi:10.1183/16000617.0133-2017 [24] de Boer GM, Zókiewicz J, Strzelec KP, et al. Bacterial lysate therapy for the prevention of wheezing episodes and asthma exacerbations: a systematic review and meta-analysis[J]. Eur Respir Rev, 2020, 29(158): 190175. doi:10.1183/16000617.0175-2019 [25] Lu YM, Li YQ, Xu LY, et al. Bacterial lysate increases the percentage of natural killer T cells in peripheral blood and alleviates asthma in children[J]. Pharmacology, 2015, 95(3/4): 139-144. doi:10.1159/000377683 [26] Liu CT, Huang R, Yao RJ, et al. The immunotherapeutic role of bacterial lysates in a mouse model of asthma[J]. Lung, 2017, 195(5): 563-569. doi:10.1007/s00408-017-0003-8 [27] Bartkowiak-Emeryk M, Emeryk A, Roliński J, et al. Impact of polyvalent mechanical bacterial lysate on lymphocyte number and activity in asthmatic children: a randomized controlled trial[J]. Allergy Asthma Clin Immunol, 2021, 17(1): 10. doi:10.1186/s13223-020-00503-4 [28] Dang AT, Pasquali C, Ludigs K, et al. OM-85 is an immunomodulator of interferon-β production and inflammasome activity[J]. Sci Rep, 2017, 7(1): 1-9. doi:10.1038/srep43844 [29] Janeczek K, Emeryk A, Rachel M, et al. Polyvalent mechanical bacterial lysate administration improves the clinical course of grass pollen-induced allergic rhinitis in children: a randomized controlled trial[J]. J Allergy Clin Immunol Pract, 2021, 9(1):453-62. doi: 10.1016/j.jaip.2020.08.025 [30] Cardinale F, Lombardi E, Rossi O, et al. Epithelial dysfunction, respiratory infections and asthma: the importance of immunomodulation. A focus on OM-85[J]. Expert Rev Respir Med, 2020, 14(10):1019-1026. doi: 10.1080/17476348.2020.1793673 [31] Jurkiewicz D, Zielnik-Jurkiewicz B. Bacterial lysates in the prevention of respiratory tract infections[J]. Otolaryngol Pol, 2018, 72(5): 1-8. doi:10.5604/01.3001.0012.7216 [32] Cao CQ, Wang JH, Li YN, et al. Efficacy and safety of OM-85 in paediatric recurrent respiratory tract infections which could have a possible protective effect on COVID-19 pandemic: a meta-analysis[J]. Int J Clin Pract, 2021, 75(5): e13981. doi:10.1111/ijcp.13981 [33] Esposito S, Cassano M, Cutrera R, et al. Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: a Delphi study[J]. Hum Vaccin Immunother, 2022, 18(6): 2106720. doi:10.1080/21645515.2022.2106720 [34] Cantarutti A, Barbieri E, Scamarcia A, et al. Use of the bacterial lysate OM-85 in the paediatric population in Italy: a retrospective cohort study[J]. Int J Environ Res Public Health, 2021, 18(13): 6871. doi:10.3390/ijerph18136871 [35] Esposito S, Bianchini S, Bosis S, et al. A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections[J]. J Transl Med, 2019, 17(1): 284. doi:10.1186/s12967-019-2040-y [36] Koatz AM, Coe NA, Cicerán A, et al. Clinical and immunological benefits of OM-85 bacterial lysate in patients with allergic rhinitis, asthma, and COPD and recurrent respiratory infections[J]. Lung, 2016, 194(4): 687-697. doi:10.1007/s00408-016-9880-5 [37] Cinicola BL, Brindisi G, Capponi M, et al. The allergic phenotype of children and adolescents with selective IgA deficiency: a longitudinal monocentric study[J]. J Clin Med, 2022, 11(19): 5705. doi:10.3390/jcm11195705 [38] Banche G, Allizond V, Mandras N, et al. Improvement of clinical response in allergic rhinitis patients treated with an oral immunostimulating bacterial lysate: in vivo immunological effects[J]. Int J Immunopathol Pharmacol, 2007, 20(1): 129-138. doi:10.1177/039463200702000115 [39] Janeczek K, Emeryk A, Rapiejko P. Effect of polyvalent bacterial lysate on the clinical course of pollen allergic rhinitis in children[J]. Pdia, 2019, 36(4): 504-505. doi:10.5114/ada.2019.87457 [40] Kowalska M, Emeryk A, Janeczek K, et al. Effect of nasal polivalent bacterial lysate on the clinical course of seasonal allergic rhinitis in children-preliminary study[C] //Paediatric asthma and allergy. European Respiratory Society, 2020: 56(suppl 64): 1208. doi:10.1183/13993003.congress-2020.1208 [41] Kaczynska A, Klosinska M, Janeczek K, et al. Promising immunomodulatory effects of bacterial lysates in allergic diseases[J]. Front Immunol, 2022, 13: 907149. doi:10.3389/fimmu.2022.907149 [42] Janeczek K, Kaczyńska A, Emeryk A, et al. Perspectives for the use of bacterial lysates for the treatment of allergic rhinitis: a systematic review[J]. J Asthma Allergy, 2022, 15: 839-850. doi:10.2147/jaa.s360828 [43] Janeczek K, Kowalska W, Zarobkiewicz M, et al. Effect of immunostimulation with bacterial lysate on the clinical course of allergic rhinitis and the level of gdT, iNKT and cytotoxic T cells in children sensitized to grass pollen allergens: A randomized controlled trial[J]. Front Immunol, 2023, 14:1073788. doi: 10.3389/fimmu.2023.1073788 |
| [1] | YANG Guanying, LI Yuanbin. Advances in the application of artificial intelligence to dry eye disease management [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 115-120. |
| [2] | LYU Qian, TANG Yuan, GU Zijun, SHI Sailei, LIU Ping, WAN Wenjin. Current status of benefit finding among patients with allergic rhinitis and its influence factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 21-28. |
| [3] | ZHU Mingqiong, LI Zheng, LIU Ru, TIAN Tao, PENG Jingli, LYU Qianyi, TAN Huaxia. The application of AI screening system based on OCT/OCTA in the evaluation of the effect of anti VEGF treatment in patients with diabetes macular edema [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 68-73. |
| [4] | GU Min, LU Meiping. Advances in the application of nanomedicine delivery systems in allergen immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 106-111. |
| [5] | CHENG Zhuo, LIANG Hui, XING Lumin. Research progress and prospect analysis of deep learning technology in the application of pharyngeal and laryngeal endoscopy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(1): 112-119. |
| [6] | QIN Nana, LI Yufen, SUN Yuhao, WEI Jian, LI Qin. Effect of interleukin-13 receptor-α2 on nasal mucosal remodeling in rats with allergic rhinitis by TGF-β1/Smad signaling pathway [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 71-77. |
| [7] | DU Kangli, ZHENG Zhenyu, XU Zhanjiang, ZHANG Yu, CHEN Lu, LU Mengyao. Construction and validation of risk prediction model for nasal septal deviation complicated with chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 78-86. |
| [8] | XIONG Qin, ZHANG Yan, WU Rina, LI Feng, TANG Lixing. Application of intranasal corticosteroids in pediatrics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(6): 160-167. |
| [9] | XU Xuemeng, FAN Lei, YU Wangbo, JIANG Zhiyue, PAN Chen, HUANG Yongqin. Meta-analysis of the efficacy of omalizumab in combination with specific immunotherapy for allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 26-33. |
| [10] | HUANG Huan, HUA Hongli, DENG Yuqin, JIANG Chengyang, WANG Yuwei, YANG Xinghai. Correlation of allergic rhinitis, tonsil adenoid hypertrophy, and sinusitis in children and analysis of its clinical guiding value [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 34-41. |
| [11] | LIU Yijun, GU Yue, GUAN Dayu, YANG Yucheng, SHEN Yang. The long-term clinical efficacy and safety of vidian neurectomy in refractory allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 42-48. |
| [12] | ZHANG Ting, WANG Meilan, GAO Yingqin. Research progress of IL-35 in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 139-147. |
| [13] | ZHANG Zhuping, PENG Zican, XIAO Zhenlong, LI Cheng, YU Di, WANG Xinglong, CHEN Wei, Guo Bei. The value of a novel nasal secretion eosinophil cationic protein-myeloperoxidase test paper assay in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 129-134. |
| [14] | CHEN Liqun, HALIMUBIEKE Shamali, WANG jing, WANG Fujiang, Yi Xianglong. Changes of ocular surface parameters of digital eye strain and its prevention and mitigation measures [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 177-182. |
| [15] | ZHANG Guoming, WEI Wenbin, LIN Haotian, CHI Wei, ZHANG Shaochong, ZHAO Peiquan, LEI Baiying, CHEN Youxin, WANG Yusheng, HE Mingguang, LIANG Jianhong, LU Hai, LU Fang, HUANG Xin, LIANG Xiaoling, ZHAO Xinyu, WU Zhenquan, YU Zhen, CUI Kaixuan, LIU Yaling, XIANG Daoman, CHEN Changzheng, ZHANG Zifeng, LIN Duoru, YU Shanshan, SUN Yue, TAN Tao, CHEN Yanxian, PENG Jie, DONG Li, CHENG Yong, ZHU Xuemei, YANG Peng, CHEN Shaobin. Expert consensus on AI-assisted diagnosis and treatment of retinopathy of prematurity(2025) [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 1-5. |
|
||